126 related articles for article (PubMed ID: 3976516)
1. Immediate hemodynamic effects of urapidil in patients with essential hypertension.
Kobrin I; Amodeo C; Ventura HO; Messerli FH; Frohlich ED
Am J Cardiol; 1985 Mar; 55(6):722-5. PubMed ID: 3976516
[TBL] [Abstract][Full Text] [Related]
2. Urapidil-induced hemodynamic changes in humans.
Bielen E; Fagard R; Staessen J; Lijnen P; Van Hoof R; Amery A
Am J Cardiol; 1989 Aug; 64(7):16D-21D. PubMed ID: 2667309
[TBL] [Abstract][Full Text] [Related]
3. [Hemodynamic effects of urapidil in men].
M'Buyamba-Kabangu JR; Bielen E; Staessen J; Fagard R; Lijnen P; Van Hoof R; Amery A
Presse Med; 1990 Sep; 19(30):1407-11. PubMed ID: 2146624
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamic effects of urapidil in arterial hypertension and congestive heart failure.
Messerli FH
Drugs; 1988; 35 Suppl 6():70-3. PubMed ID: 3042361
[TBL] [Abstract][Full Text] [Related]
5. Urapidil in normotensive and spontaneously hypertensive rats: the effects on systemic and regional haemodynamics and cardiac mass.
Kobrin I; Gallo AJ; Pegram BL; Frohlich ED
J Hypertens; 1984 Jun; 2(3):317-20. PubMed ID: 6530543
[TBL] [Abstract][Full Text] [Related]
6. Acute responses to urapidil in hypertensive persons.
de Leeuw PW; Birkenhäger WH
Am J Cardiol; 1989 Aug; 64(7):22D-24D. PubMed ID: 2667310
[TBL] [Abstract][Full Text] [Related]
7. [The effect of urapidil on blood pressure, renal hemodynamics, lipid and glucose metabolism].
Sanjuliani AF; Fagundes VG; Francischetti EA
Arq Bras Cardiol; 1995 Jul; 65(1):59-63. PubMed ID: 8546598
[TBL] [Abstract][Full Text] [Related]
8. Effects of Direct Renin Blockade on Renal & Systemic Hemodynamics and on RAAS Activity, in Weight Excess and Hypertension: A Randomized Clinical Trial.
Kwakernaak AJ; Roksnoer LC; Lambers Heerspink HJ; van den Berg-Garrelds I; Lochorn GA; van Embden Andres JH; Klijn MA; Kobori H; Danser AH; Laverman GD; Navis GJ
PLoS One; 2017; 12(1):e0169258. PubMed ID: 28118402
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamics, biochemical and reflexive changes produced by atenolol in hypertension.
Dreslinski GR; Messerli FH; Dunn FG; Suarez DH; Reisin E; Frohlich ED
Circulation; 1982 Jun; 65(7):1365-8. PubMed ID: 6122514
[TBL] [Abstract][Full Text] [Related]
10. Immediate hemodynamic changes produced by urapidil in normotensive and spontaneously hypertensive rats.
Kobrin I; Gallo A; Kumar A; Pegram BL; Frohlich ED
Clin Exp Hypertens A; 1984; 6(3):685-97. PubMed ID: 6723085
[TBL] [Abstract][Full Text] [Related]
11. Correlation between peripheral hemodynamic changes and left ventricular diastolic function in hypertensive patients treated with urapidil.
Arosio E; Pancera P; Sheiban I; Priante F; Ribul M; De Marchi S; Tonni S; Lechi A
J Hum Hypertens; 1996 Mar; 10(3):171-6. PubMed ID: 8733035
[TBL] [Abstract][Full Text] [Related]
12. Renal haemodynamic and neurohumoral responses to urapidil in hypertensive man.
de Leeuw PW; van Es PN; de Bruyn HA; Birkenhäger WH
Drugs; 1988; 35 Suppl 6():74-7. PubMed ID: 2900132
[TBL] [Abstract][Full Text] [Related]
13. Immediate and short-term cardiovascular effects of fosinopril, a new angiotensin-converting enzyme inhibitor, in patients with essential hypertension.
Oren S; Messerli FH; Grossman E; Garavaglia GE; Frohlich ED
J Am Coll Cardiol; 1991 Apr; 17(5):1183-7. PubMed ID: 1826120
[TBL] [Abstract][Full Text] [Related]
14. Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension.
Dunn FG; Oigman W; Ventura HO; Messerli FH; Kobrin I; Frohlich ED
Am J Cardiol; 1984 Jan; 53(1):105-8. PubMed ID: 6318542
[TBL] [Abstract][Full Text] [Related]
15. Immediate and short-term hemodynamic effects of diltiazem in patients with hypertension.
Amodeo C; Kobrin I; Ventura HO; Messerli FH; Frohlich ED
Circulation; 1986 Jan; 73(1):108-13. PubMed ID: 3510085
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine.
Adnot S; Defouilloy C; Brun-Buisson C; Abrouk F; Piquet J; Lemaire F
Am Rev Respir Dis; 1987 Feb; 135(2):288-93. PubMed ID: 3813189
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacology of urapidil.
Prichard BN; Renondin JC; Tomlinson B
J Hypertens Suppl; 1988 Dec; 6(2):S13-9. PubMed ID: 2906695
[TBL] [Abstract][Full Text] [Related]
18. Systemic haemodynamic and humoral changes during urapidil treatment in hypertensive patients.
Leonetti G; Terzoli L; Zanchetti A
J Hypertens Suppl; 1988 Dec; 6(2):S25-9. PubMed ID: 2906697
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects and regional blood flow distribution associated with angiotensin converting enzyme inhibition (captopril) in essential hypertension.
Ventura HO; Frohlich ED; Messerli FH; Kobrin I; Kardon MB
Am J Cardiol; 1985 Apr; 55(8):1023-6. PubMed ID: 2984914
[TBL] [Abstract][Full Text] [Related]
20. Systemic and renal hemodynamic effects of trimazosin: a new vasodilator.
Chrysant SG; Luu TM; Danisa K; Kem DC; Manion CV
J Cardiovasc Pharmacol; 1980; 2(2):205-14. PubMed ID: 6171687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
